{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-037674","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.860641+00:00","generated_at":"2026-06-21T20:41:09.325245+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ra Medical Systems reports Q3 2022 loss, no revenue; merger with Catheter Precision progressing","bullets":["Q3 2022 revenue $0; loss from continuing ops $4.8M ($4.36/share) vs $7.4M loss in Q3 2021.","Adjusted EBITDA negative $4.1M, improved from negative $6.9M in Q3 2021.","Cash and equivalents $13.7M at Sept 30; raised ~$4.9M after quarter via ATM.","Proposed reverse merger with Catheter Precision on track for late 2022/early 2023; Catheter stakeholders to own ~80%.","Effected 1-for-50 reverse stock split on Oct 3 to maintain NYSE American listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-037674","json":"https://secwatch.observer/filing/0001564590-22-037674.json","markdown":"https://secwatch.observer/filing/0001564590-22-037674.md","text":"https://secwatch.observer/filing/0001564590-22-037674.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022037674/0001564590-22-037674-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022037674/rmed-8k_20221114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T20:41:09.325245+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5d8531e3a385ebb1d1cda541675624585781057a","claim":"Catheter Precision, Inc. reported financial results for the nine months ended September 30, 2022.","evidence_excerpt":"On November 14, 2022, Ra Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the three and nine months ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022037674/0001564590-22-037674-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the nine months ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ac81d6534b042d3fec31e1116b3dcff8cedbc1c0","claim":"Catheter Precision, Inc. reported financial results for the three months ended September 30, 2022.","evidence_excerpt":"On November 14, 2022, Ra Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the three and nine months ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022037674/0001564590-22-037674-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}